T1	CHEM 1 12	Gabapentina
#1	AnnotatorNotes T1	C0060926; gabapentin; Organic Chemical · Pharmacologic Substance
T2	PROC 1135 1138	EVN
#2	AnnotatorNotes T2	C4275132; Assessment using Verbal Rating Scale; Diagnostic Procedure
T3	CHEM 32 41	adyuvante
#3	AnnotatorNotes T3	C0001551; Immunologic Adjuvants; Immunologic Factor · Pharmacologic Substance
T4	DISO 59 85	dolor agudo postoperatorio
#4	AnnotatorNotes T4	C2215257; Postoperative Pain, Acute; Sign or Symptom
T5	PROC 89 112	histerectomía abdominal
#5	AnnotatorNotes T5	C0404077; Abdominal hysterectomy; Therapeutic or Preventive Procedure
T6	PROC 1641 1644	EVN
#6	AnnotatorNotes T6	C4275132; Assessment using Verbal Rating Scale; Diagnostic Procedure
T7	DISO 161 178	síntoma subjetivo
T8	DISO 184 204	dolor postoperatorio
#7	AnnotatorNotes T8	C0030201; Pain, Postoperative; Sign or Symptom
T9	PROC 300 309	erradicar
#8	AnnotatorNotes T9	C3178994; Disease Eradication; Health Care Activity
T10	DISO 384 410	dolor agudo postoperatorio
#9	AnnotatorNotes T10	C2215257; Postoperative Pain, Acute; Sign or Symptom
T11	CHEM 424 435	gabapentina
#10	AnnotatorNotes T11	C0060926; gabapentin; Organic Chemical · Pharmacologic Substance
T12	PROC 494 517	histerectomía abdominal
#11	AnnotatorNotes T12	C0404077; Abdominal hysterectomy; Therapeutic or Preventive Procedure
T13	PROC 705 728	histerectomía abdominal
#12	AnnotatorNotes T13	C0404077; Abdominal hysterectomy; Therapeutic or Preventive Procedure
T14	PROC 733 750	anestesia general
#13	AnnotatorNotes T14	C0002915; General Anesthesia; Therapeutic or Preventive Procedure
T15	CHEM 787 798	gabapentina
#14	AnnotatorNotes T15	C0060926; gabapentin; Organic Chemical · Pharmacologic Substance
T16	CHEM 800 811	gabapentina
#15	AnnotatorNotes T16	C0060926; gabapentin; Organic Chemical · Pharmacologic Substance
T17	PROC 843 852	analgesia
#16	AnnotatorNotes T17	C3202977; Analgesia; Therapeutic or Preventive Procedure
T18	PROC 886 922	analgesia controlada por el paciente
#17	AnnotatorNotes T18	C0078944; Patient-Controlled Analgesia; Therapeutic or Preventive Procedure
T19	PROC 924 927	PCA
#18	AnnotatorNotes T19	C0078944; Patient-Controlled Analgesia; Therapeutic or Preventive Procedure
T20	PROC 947 956	analgesia
#19	AnnotatorNotes T20	C3202977; Analgesia; Therapeutic or Preventive Procedure
T21	PROC 987 990	PCA
#20	AnnotatorNotes T21	C0078944; Patient-Controlled Analgesia; Therapeutic or Preventive Procedure
T22	CHEM 1004 1011	morfina
#21	AnnotatorNotes T22	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T23	PROC 1111 1133	escala verbal numérica
#22	AnnotatorNotes T23	C4275132; Assessment using Verbal Rating Scale; Diagnostic Procedure
T24	DISO 1278 1294	efectos adversos
#23	AnnotatorNotes T24	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T25	CHEM 1440 1451	gabapentina
#24	AnnotatorNotes T25	C0060926; gabapentin; Organic Chemical · Pharmacologic Substance
T26	DISO 1506 1526	dolor postoperatorio
#25	AnnotatorNotes T26	C0030201; Pain, Postoperative; Sign or Symptom
T27	CHEM 1710 1721	gabapentina
#26	AnnotatorNotes T27	C0060926; gabapentin; Organic Chemical · Pharmacologic Substance
T28	PROC 1886 1889	PCA
#27	AnnotatorNotes T28	C0078944; Patient-Controlled Analgesia; Therapeutic or Preventive Procedure
T29	CHEM 1968 1979	gabapentina
#28	AnnotatorNotes T29	C0060926; gabapentin; Organic Chemical · Pharmacologic Substance
T30	DISO 2095 2111	efectos adversos
#29	AnnotatorNotes T30	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T31	CHEM 2215 2226	gabapentina
#30	AnnotatorNotes T31	C0060926; gabapentin; Organic Chemical · Pharmacologic Substance
T32	PROC 2325 2348	histerectomía abdominal
#31	AnnotatorNotes T32	C0404077; Abdominal hysterectomy; Therapeutic or Preventive Procedure
T33	DISO 2456 2472	efectos adversos
#32	AnnotatorNotes T33	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T34	ANAT 103 112	abdominal
#33	AnnotatorNotes T34	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T35	DISO 152 157	dolor
#34	AnnotatorNotes T35	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T36	ANAT 508 517	abdominal
#35	AnnotatorNotes T36	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T37	PROC 597 678	estudio de cohorte experimental prospectivo aleatorizado, controlado, doble ciego
#36	AnnotatorNotes T37	C1709709; Prospective Cohort Study; Research Activity + C0678323; experimentation; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity + C0013072; Double-Blind Method; Research Activity
T38	ANAT 719 728	abdominal
#37	AnnotatorNotes T38	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T39	PROC 752 765	Se aleatorizó
#38	AnnotatorNotes T39	C0034656; Randomization; Research Activity
T40	CHEM 857 864	morfina
#39	AnnotatorNotes T40	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T41	CHEM 961 968	morfina
#40	AnnotatorNotes T41	C0026549; morphine; Organic Chemical · Pharmacologic Substance
T42	DISO 1098 1103	dolor
#41	AnnotatorNotes T42	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T43	PROC 1205 1213	rescates
#42	AnnotatorNotes T43	C0085405; Salvage Therapy; Therapeutic or Preventive Procedure
T44	PROC 1850 1858	rescates
#43	AnnotatorNotes T44	C0085405; Salvage Therapy; Therapeutic or Preventive Procedure
T45	PROC 2296 2305	analgesia
#44	AnnotatorNotes T45	C3202977; Analgesia; Therapeutic or Preventive Procedure
T46	ANAT 2339 2348	abdominal
#45	AnnotatorNotes T46	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T47	Time 13 26	preoperatoria
#46	AnnotatorNotes T47	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
T48	Time 71 85	postoperatorio
#47	AnnotatorNotes T48	C0032790; Postoperative Period; Temporal Concept
T49	Time 190 204	postoperatorio
#48	AnnotatorNotes T49	C0032790; Postoperative Period; Temporal Concept
T50	Neg_cue 284 286	no
T52	Time 396 410	postoperatorio
#49	AnnotatorNotes T52	C0032790; Postoperative Period; Temporal Concept
T53	Dose 414 420	600 mg
T54	Time 455 468	preoperatorio
#50	AnnotatorNotes T54	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
T55	LIVB 472 481	pacientes
#51	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	Date 549 554	abril
T57	Date 557 571	agosto de 2014
T58	LIVB 683 692	pacientes
#52	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	Dose 812 818	600 mg
T60	Duration 819 826	2 horas
T61	Time 827 840	preoperatoria
#53	AnnotatorNotes T61	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
T62	DEVI 877 922	bomba de analgesia controlada por el paciente
#54	AnnotatorNotes T62	C0181331; PCA Pump; Medical Device
T63	LIVB 932 945	grupo control
#55	AnnotatorNotes T63	C0009932; Control Groups; Group
T64	DEVI 981 990	bomba PCA
#56	AnnotatorNotes T64	C0181331; PCA Pump; Medical Device
T65	Dose 1054 1065	0,016 mg/kg
T67	Duration 1155 1174	las 2, 6 y 24 horas
T68	Time 1234 1248	postoperatorio
#57	AnnotatorNotes T68	C0032790; Postoperative Period; Temporal Concept
T69	LIVB 1342 1351	pacientes
#58	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group
T70	Age 1410 1427	44,72 ± 6,17 años
T71	Age 1454 1471	49,36 ± 9,31 años
T72	LIVB 1478 1491	grupo control
#59	AnnotatorNotes T72	C0009932; Control Groups; Group
T73	Time 1512 1526	postoperatorio
#60	AnnotatorNotes T73	C0032790; Postoperative Period; Temporal Concept
T74	LIVB 1768 1781	grupo control
#61	AnnotatorNotes T74	C0009932; Control Groups; Group
T76	Duration 1784 1803	las 2, 6 y 24 horas
T77	DEVI 1877 1889	bomba de PCA
#62	AnnotatorNotes T77	C0181331; PCA Pump; Medical Device
T78	Duration 1898 1935	las primeras 24 horas postoperatorias
T80	LIVB 2004 2017	grupo control
#63	AnnotatorNotes T80	C0009932; Control Groups; Group
T82	Dose 2239 2245	600 mg
T83	Time 2246 2259	preoperatoria
#64	AnnotatorNotes T83	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
T84	Time 2306 2319	preoperatoria
#65	AnnotatorNotes T84	C0445204; Preoperative; Temporal Concept | C2712277; Preoperative Period; Temporal Concept
T86	LIVB 608 615	cohorte
#66	AnnotatorNotes T86	C0599755; Cohort; Population Group
T87	LIVB 914 922	paciente
#67	AnnotatorNotes T87	C0030705; Patients; Patient or Disabled Group
T51	Frequency 1065 1067	/h
T66	PROC 1047 1051	peso
#68	AnnotatorNotes T66	C2985231; Body Weight Measurement; Diagnostic Procedure
T75	PROC 1325 1338	se reclutaron
#69	AnnotatorNotes T75	C0242800; Patient Recruitment; Research Activity
A1	Assertion T9 Negated
T79	Neg_cue 2112 2114	no
T81	Quantifier_or_Qualifier 2119 2149	estadísticamente significativa
A2	Assertion T81 Negated
#70	AnnotatorNotes T81	C0237881; Statistical Significance; Quantitative Concept
R1	Negation Arg1:T79 Arg2:T81	
R2	Negation Arg1:T50 Arg2:T9	
R3	Overlap Arg1:T1 Arg2:T47	
R4	Overlap Arg1:T3 Arg2:T47	
R5	Overlap Arg1:T4 Arg2:T48	
R6	Location_of Arg1:T34 Arg2:T5	
R7	Causes Arg1:T5 Arg2:T4	
R8	Overlap Arg1:T8 Arg2:T49	
R11	Overlap Arg1:T10 Arg2:T52	
R12	Has_Dose_or_Strength Arg1:T11 Arg2:T53	
R13	Overlap Arg1:T11 Arg2:T54	
R14	Before Arg1:T1 Arg2:T5	
R15	Before Arg1:T11 Arg2:T12	
R16	Causes Arg1:T12 Arg2:T10	
R17	Location_of Arg1:T36 Arg2:T12	
R18	Experiences Arg1:T55 Arg2:T12	
R19	Experiences Arg1:T55 Arg2:T11	
R20	Experiences Arg1:T55 Arg2:T10	
R21	After Arg1:T12 Arg2:T56	
R22	Before Arg1:T12 Arg2:T57	
R23	Experiences Arg1:T86 Arg2:T13	
R24	Location_of Arg1:T38 Arg2:T13	
R25	Experiences Arg1:T58 Arg2:T13	
R26	Before Arg1:T14 Arg2:T13	
R27	Experiences Arg1:T58 Arg2:T14	
R28	Experiences Arg1:T86 Arg2:T14	
R29	Before Arg1:T39 Arg2:T15	
R30	Has_Dose_or_Strength Arg1:T16 Arg2:T59	
R31	Has_Duration_or_Interval Arg1:T16 Arg2:T60	
R32	Overlap Arg1:T16 Arg2:T61	
R33	Before Arg1:T16 Arg2:T17	
R34	Used_for Arg1:T40 Arg2:T17	
R36	Experiences Arg1:T87 Arg2:T18	
R37	Used_for Arg1:T62 Arg2:T18	
R35	Used_for Arg1:T62 Arg2:T19	
R38	Experiences Arg1:T87 Arg2:T19	
R39	Experiences Arg1:T87 Arg2:T17	
R40	Experiences Arg1:T87 Arg2:T16	
R41	Before Arg1:T15 Arg2:T17	
R42	Experiences Arg1:T87 Arg2:T15	
R43	Has_Dose_or_Strength Arg1:T15 Arg2:T59	
R44	Has_Duration_or_Interval Arg1:T15 Arg2:T60	
R45	Overlap Arg1:T15 Arg2:T61	
R46	Before Arg1:T16 Arg2:T18	
R47	Before Arg1:T16 Arg2:T19	
R48	Before Arg1:T39 Arg2:T20	
R49	Used_for Arg1:T41 Arg2:T20	
R50	Experiences Arg1:T63 Arg2:T20	
R51	Used_for Arg1:T64 Arg2:T21	
R52	Used_for Arg1:T64 Arg2:T20	
R53	Used_for Arg1:T62 Arg2:T17	
R54	Experiences Arg1:T63 Arg2:T21	
R55	Has_Dose_or_Strength Arg1:T22 Arg2:T65	
R56	Experiences Arg1:T63 Arg2:T22	
R57	Experiences Arg1:T63 Arg2:T66	
R58	Has_Frequency Arg1:T22 Arg2:T51	
R61	Overlap Arg1:T2 Arg2:T67	
R62	Overlap Arg1:T23 Arg2:T67	
R63	Overlap Arg1:T43 Arg2:T68	
R64	Overlap Arg1:T42 Arg2:T68	
R65	Overlap Arg1:T24 Arg2:T68	
R66	Has_Age Arg1:T69 Arg2:T70	
R67	Experiences Arg1:T69 Arg2:T25	
R68	Has_Age Arg1:T72 Arg2:T71	
R69	Before Arg1:T75 Arg2:T25	
R70	Overlap Arg1:T26 Arg2:T73	
R72	Experiences Arg1:T74 Arg2:T6	
R73	Overlap Arg1:T6 Arg2:T76	
R74	Used_for Arg1:T77 Arg2:T28	
R75	Used_for Arg1:T77 Arg2:T44	
R76	Has_Duration_or_Interval Arg1:T44 Arg2:T78	
R77	Has_Duration_or_Interval Arg1:T28 Arg2:T78	
R78	Before Arg1:T29 Arg2:T44	
R79	Experiences Arg1:T80 Arg2:T44	
R80	Experiences Arg1:T80 Arg2:T28	
R81	Experiences Arg1:T80 Arg2:T6	
R82	Experiences Arg1:T80 Arg2:T26	
R83	Experiences Arg1:T74 Arg2:T44	
R84	Experiences Arg1:T74 Arg2:T28	
R85	Experiences Arg1:T74 Arg2:T26	
R86	Experiences Arg1:T74 Arg2:T30	
R87	Experiences Arg1:T80 Arg2:T30	
R88	Before Arg1:T27 Arg2:T30	
R89	Before Arg1:T29 Arg2:T30	
R90	Has_Dose_or_Strength Arg1:T31 Arg2:T82	
R91	Overlap Arg1:T31 Arg2:T83	
R92	Used_for Arg1:T31 Arg2:T45	
R93	Overlap Arg1:T45 Arg2:T84	
R94	Before Arg1:T45 Arg2:T32	
R95	Location_of Arg1:T46 Arg2:T32	
T85	Observation 346 362	efecto adyuvante
R9	Causes Arg1:T11 Arg2:T85	
R10	Overlap Arg1:T42 Arg2:T67	
R59	Experiences Arg1:T69 Arg2:T75	
R60	Experiences Arg1:T72 Arg2:T75	
A3	Experiencer T55 Patient
A4	Experiencer T86 Patient
A5	Experiencer T58 Patient
A6	Experiencer T63 Patient
A7	Experiencer T87 Patient
A8	Experiencer T69 Patient
A9	Experiencer T72 Patient
A10	Experiencer T74 Patient
A11	Experiencer T80 Patient
